You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Details for New Drug Application (NDA): 020517


✉ Email this page to a colleague

« Back to Dashboard


NDA 020517 describes LUPRON DEPOT, which is a drug marketed by Abbvie Endocrine Inc and is included in five NDAs. It is available from one supplier. There are two patents protecting this drug. Additional details are available on the LUPRON DEPOT profile page.

The generic ingredient in LUPRON DEPOT is leuprolide acetate. There are twenty-two drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the leuprolide acetate profile page.
Summary for 020517
Tradename:LUPRON DEPOT
Applicant:Abbvie Endocrine Inc
Ingredient:leuprolide acetate
Patents:1
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 020517
Suppliers and Packaging for NDA: 020517
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LUPRON DEPOT leuprolide acetate INJECTABLE;INJECTION 020517 NDA AbbVie Inc. 0074-3346 0074-3346-03 1 KIT in 1 CARTON (0074-3346-03) * 1.5 mL in 1 SYRINGE * 1 SWAB in 1 PACKET
LUPRON DEPOT leuprolide acetate INJECTABLE;INJECTION 020517 NDA AbbVie Inc. 0074-3473 0074-3473-03 1 KIT in 1 CARTON (0074-3473-03) * 1.5 mL in 1 SYRINGE * 1 SWAB in 1 PACKET

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength22.5MG
Approval Date:Dec 22, 1995TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength30MG
Approval Date:May 30, 1997TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength45MG
Approval Date:Jun 17, 2011TE:RLD:Yes
Patent:⤷  Try a TrialPatent Expiration:Feb 5, 2031Product Flag?YSubstance Flag?Delist Request?
Patented Use:PALLIATIVE TREATMENT OF PROSTATE CANCER

Expired US Patents for NDA 020517

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie Endocrine Inc LUPRON DEPOT leuprolide acetate INJECTABLE;INJECTION 020517-001 Dec 22, 1995 ⤷  Try a Trial ⤷  Try a Trial
Abbvie Endocrine Inc LUPRON DEPOT leuprolide acetate INJECTABLE;INJECTION 020517-002 May 30, 1997 ⤷  Try a Trial ⤷  Try a Trial
Abbvie Endocrine Inc LUPRON DEPOT leuprolide acetate INJECTABLE;INJECTION 020517-003 Jun 17, 2011 ⤷  Try a Trial ⤷  Try a Trial
Abbvie Endocrine Inc LUPRON DEPOT leuprolide acetate INJECTABLE;INJECTION 020517-001 Dec 22, 1995 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.